ACT Biotech Inc
id:
act-biotech-inc-194-13210685
title:
ACT Biotech Inc
text:
ACT Biotech Inc is a San Francisco-based, privately held biopharmaceutical company focused on the development and commercialization of targeted cancer drugs. It was founded in 2008. The Company's clinical stage pipeline includes: Telatinib, an oral kinase inhibitor for the first-line treatment of advanced gastric cancer. It has been granted Orphan Drug status by the U.S. Food and Drug Administration (FDA). It has reported encouraging interim results from a phase II trial.
ACTB1003, an oral kinas
brand slug:
wiki
category slug:
encyclopedia
description:
American biopharmaceutical company
original url:
https://en.wikipedia.org/wiki/ACT_Biotech_Inc
date created:
date modified:
2023-12-22T06:18:02Z
main entity:
{"identifier":"Q4650874","url":"https://www.wikidata.org/entity/Q4650874"}
image:
fields total:
13
integrity:
14